Zdrowie i gospodarka · 07/02/2001
FDA Releases Draft Guidance on Xenotransplantation Products
The Food and Drug Administration (FDA) has made available a draft guidance document addressing issues related to the use of xenotransplantation products in humans, focusing on source animal, product, preclinical, and clinical concerns.
Source: Federal Register — Food and Drug AdministrationOpen original release →